Related Experiment Video
Updated: Apr 5, 2026

Isolation and Enrichment of Human Adipose-derived Stromal Cells for Enhanced Osteogenesis
Published on: January 12, 2015
Transcriptional profiling of interleukin-2-primed human adipose derived mesenchymal stem cells revealed dramatic
Ping Niu1, Aibek Smagul2, Lu Wang3
1Department of Pediatrics, Renmin Hospital of Wuhan University, Wuhan, China.
Abstract:
Inflammation is a double-edged sword with both detrimental and beneficial consequences. Understanding of the mechanisms of crosstalk between the inflammatory milieu and human adult mesenchymal stem cells is an important basis for clinical efforts. Here, we investigate changes in the transcriptional response of human adipose-derived stem cells to physiologically relevant levels of IL-2 (IL-2 priming) upon replicative senescence. Our data suggest that replicative senescence might dramatically impede human mesenchymal stem cell (MSC) function via global transcriptional deregulation in response to IL-2. We uncovered a novel senescence-associated transcriptional signature in human adipose-derived MSCs hADSCs after exposure to pro-inflammatory environment: significant enhancement of the expression of the genes encoding potent growth factors and cytokines with anti-inflammatory and migration-promoting properties, as well as genes encoding angiogenic and anti-apoptotic promoting factors, all of which could participate in the establishment of a unique microenvironment. We observed transcriptional up-regulation of critical components of the nitric oxide synthase pathway (iNOS) in hADSCs upon replicative senescence suggesting, that senescent stem cells can acquire metastasis-promoting properties via stem cell-mediated immunosuppression. Our study highlights the importance of age as a factor when designing cell-based or pharmacological therapies for older patients and predicts measurable biomarkers characteristic of an environment that is conducive to cancer cells invasiveness and metastasis.
Insights
Replicative senescence impairs human mesenchymal stem cell function and alters their response to IL-2. Senescent cells may promote cancer metastasis through immunosuppression, highlighting age as a critical factor in cell therapies.
Area of Science:
- Stem cell biology
- Immunology
- Oncology
Background:
- Mesenchymal stem cells (MSCs) interact with inflammatory environments, crucial for clinical applications.
- Understanding this crosstalk is vital for developing effective cell-based therapies.
Purpose of the Study:
- To investigate how replicative senescence affects human adipose-derived stem cells (hADSCs) transcriptional response to IL-2.
- To identify senescence-associated transcriptional changes and their functional implications.
Main Methods:
- Exposure of hADSCs to IL-2 (IL-2 priming) at physiologically relevant levels.
- Analysis of transcriptional response in senescent versus non-senescent cells.
- Identification of key gene expression changes, including iNOS.
Main Results:
- Replicative senescence significantly alters hADSC transcriptional response to IL-2, potentially impairing MSC function.
- Senescent hADSCs exhibit enhanced expression of genes promoting anti-inflammatory, migration, angiogenic, and anti-apoptotic effects.
- Up-regulation of inducible nitric oxide synthase (iNOS) in senescent hADSCs suggests potential metastasis-promoting properties via immunosuppression.
Conclusions:
- Replicative senescence profoundly impacts hADSC function and their inflammatory response.
- Senescent stem cells may create a pro-metastatic microenvironment through immunosuppression.
- Age is a critical consideration for cell-based and pharmacological therapies, with potential biomarkers for cancer invasiveness identified.
More Related Videos
10:50Author Spotlight: Isolation and Identification of Mesenchymal Stem Cells Derived from Adipose Tissue of Sprague Dawley Rats
Published on: April 7, 2023
10:28Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
Published on: July 17, 2018